Name |
Recombinant Human IL-1 RAPL2/IL-1 R9 Fc Chimera Protein, CF
|
Supplier |
R&D Systems
|
Catalog |
1007-MR
|
Category |
Protein
|
Prices |
$329.00
|
Sizes |
100 µg
|
Species Reactivities |
Human
|
Nature |
Recombinant
|
Source |
Mouse myeloma cell line, NS0-derived Human IL-1 RAPL2 (Thr17-Glu356) & (Lys20-Glu356) Accession # Q9NP60 DIEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
Purity |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
|
Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human IL-1 RAPL2/IL-1 R9 Fc Chimera is immobilized at 1 μg/well, the concentration of Recombinant Human IL‑1 Rrp2/IL‑1 R6 Fc Chimera (Catalog # 872-RP ) that produces 50% of the optimal binding response is found to be approximately 2-8 μg/mL.
|
Endotoxin |
<0.01 EU per 1 μg of the protein by the LAL method.
|
SwissProt/Accession |
Q9NP60
|
Gene |
IL1RAPL2
|
Sequence |
Thr17 & Lys20
|
Supplier Page |
Shop
|